<?xml version="1.0" encoding="UTF-8"?>
<p>For fecal samples, laboratories prepared a 10% fecal suspension by mixing 0.1 g feces with 1.0 mL phosphate-buffered saline (pH 7.2). For swab or vomitus samples, nucleic acid was extracted directly. Laboratories tested viral RNA for GI and GII norovirus using the Ag-Path kit (Applied Biosystems, 
 <ext-link ext-link-type="uri" xlink:href="https://www.fishersci.com" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.fishersci.com</ext-link>) (
 <xref rid="R7" ref-type="bibr">
  <italic>7</italic>
 </xref>,
 <xref rid="R14" ref-type="bibr">
  <italic>14</italic>
 </xref>) in a duplex rRT-PCR with primers (Cog1F, Cog1R, Cog2F, and Cog2R) (
 <xref rid="R11" ref-type="bibr">
  <italic>11</italic>
 </xref>) and TaqMan probe (Ring 1E and Ring 2) (
 <xref rid="R14" ref-type="bibr">
  <italic>14</italic>
 </xref>,
 <xref rid="R15" ref-type="bibr">
  <italic>15</italic>
 </xref>). The cycling conditions were described previously (
 <xref rid="R7" ref-type="bibr">
  <italic>7</italic>
 </xref>). Some laboratories also used commercial norovirus rRT-PCR kits (BioPerfectus Technology Co., 
 <ext-link ext-link-type="uri" xlink:href="http://www.s-sbio.net" xmlns:xlink="http://www.w3.org/1999/xlink">http://www.s-sbio.net</ext-link>; Da An GENE Co., 
 <ext-link ext-link-type="uri" xlink:href="http://en.daangene.com" xmlns:xlink="http://www.w3.org/1999/xlink">http://en.daangene.com</ext-link>). Norovirus-positive samples were then amplified by conventional RT-PCR, which amplifies a partial region of ORF1 and a partial region of ORF2 (
 <xref rid="R7" ref-type="bibr">
  <italic>7</italic>
 </xref>,
 <xref rid="R16" ref-type="bibr">
  <italic>16</italic>
 </xref>). The RT-PCR conditions and the primers used (MON432, G1SKR, MON431, and G2SKR) have been described previously (
 <xref rid="R7" ref-type="bibr">
  <italic>7</italic>
 </xref>,
 <xref rid="R16" ref-type="bibr">
  <italic>16</italic>
 </xref>).
</p>
